Apellis Pharmaceuticals Inc
APLSLatest QuantConomy context for APLS: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Apellis Pharmaceuticals Inc
QuantConomy has a structured record for APLS. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- APLS
- Name
- Apellis Pharmaceuticals Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for APLS
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 12, 12:00 AM | APLS filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| material agreement | very bearish | 100 | May 14, 12:50 PM | APLS filed 8-K: Modification to Rights of Security Holders, Change in Control, Director or Officer Changes - 9 material events - [very strong very bearish signal] |
| executive change | neutral | 75 | May 4, 11:10 AM | APLS filed 8-K: Director or Officer Changes - 1 material event - [strong neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| APLS | NASDAQ | fmp | Apellis Pharmaceuticals, Inc. |
| APLS | NASDAQ | alphavantage | Apellis Pharmaceuticals Inc |
| APLS | NASDAQ | alpaca | Apellis Pharmaceuticals, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | O'Brien Stephanie Monaghan | Director | other | 25,666 | — | — | 4 on EDGAR |
| May 14, 2026 | WHEELER CRAIG A | Director | other | 24,444 | — | — | 4 on EDGAR |
| May 14, 2026 | Nicholson Nur | Chief Technical Officer | other | 116,338 | — | — | 4 on EDGAR |
| May 14, 2026 | Walbert Keli | Director | other | 17,051 | — | — | 4 on EDGAR |
| May 14, 2026 | Deschatelets Pascal | Chief Scientific Officer | other | 1,177,222 | — | — | 4 on EDGAR |
| May 14, 2026 | Dolsten Mikael | Director | other | 14,312 | — | — | 4 on EDGAR |
| May 14, 2026 | Sullivan Timothy Eugene | Chief Financial Officer | other | 140,945 | — | — | 4 on EDGAR |
| May 14, 2026 | Dunlop A. Sinclair | Director | other | 161,567 | — | — | 4 on EDGAR |
| May 14, 2026 | FONTEYNE PAUL R. | Director | other | 30,666 | — | — | 4 on EDGAR |
| May 14, 2026 | Chopas James George | VP/Chief Accounting Officer | other | 65,955 | — | — | 4 on EDGAR |
| May 14, 2026 | Baumal Caroline | Chief Medical Officer | other | 86,525 | — | — | 4 on EDGAR |
| May 14, 2026 | Machiels Alec | Director | other | 384,989 | — | — | 4 on EDGAR |
| May 14, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | other | 114,591 | — | — | 4 on EDGAR |
| May 14, 2026 | Watson David O. | General Counsel | other | 144,517 | — | — | 4 on EDGAR |
| May 14, 2026 | Francois Cedric | Chief Executive Officer | other | 425,968 | — | — | 4 on EDGAR |
| May 14, 2026 | Boucher Kelley | Chief People Officer | other | 127,804 | — | — | 4 on EDGAR |
| May 14, 2026 | MELTZER LESLIE | Chief Research and Development | other | 107,024 | — | — | 4 on EDGAR |
| May 14, 2026 | Chan Gerald | Director | other | 25,666 | — | — | 4 on EDGAR |
| Apr 29, 2026 | Baumal Caroline | Chief Medical Officer | gift | 900 | $0.00 | $0 | 4 on EDGAR |
| Apr 17, 2026 | Sullivan Timothy Eugene | Chief Financial Officer | gift | 11,096 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query APLS context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access